Long-term intake experiment of D-psicose for type 2 diabetic patients

Long-term intake experiment of D-psicose for type 2 diabetic patients - Long-term intake experiment of D-psicose for type 2 diabetic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027143

Enrollment

Registered

2017-04-26

Start date

2017-03-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Ingestion of the test product for 12 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.fasting blood glucose level 126 mg / dL or more or HbA 1 c (NGSP) 6.5% or more 2. LDL-C high price person (LDL-C 120 mg / dL or more and less than 160 mg / dL) 3. Persons who are taking medication for treating diabetes or who are administering insulin

Exclusion criteria

Exclusion criteria: 1.Patients falling under D-psicose administration contraindications 2.Patients taking oral administration of HMG-CoA reductase inhibitor 3.Patients participating in other clinical trials 4.Pregnant women, maternity women, lactating women or women with the possibility of pregnancy 5.Patients who have poor glycemic control with HbA1c> 8% 6.Patients who have severe renal dysfunction (serum creatinine value> 1.5 mg / dl) 7.Patients with other serious complications 8.Other patients judged inappropriate as judged by doctors

Design outcomes

Primary

Measure	Time frame
Evaluate the fluctuation of the value of LDL-C before and after administration of D-psicose	—

Countries

Japan

Contacts

Public ContactKoji murao

Kagawa University department of endocrinology and metabolism

labmed@med.kagawa-u.ac.jp087-891-2230

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026